1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000; 342:1334–1349.
2. Dushianthan A, Grocott MP, Postle AD, Cusack R. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J. 2011; 87:612–622.
3. Duggal A, Ganapathy A, Ratnapalan M, Adhikari NK. Pharmacological treatments for acute respiratory distress syndrome: systematic review. Minerva Anestesiol. 2015; 81:567–588.
4. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med. 2000; 28:2187–2192.
5. Honiden S, Gong MN. Diabetes, insulin, and development of acute lung injury. Crit Care Med. 2009; 37:2455–2464.
6. Zmijewski JW, Lorne E, Zhao X, Tsuruta Y, Sha Y, Liu G, et al. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med. 2008; 178:168–179.
7. Morales AI, Detaille D, Prieto M, Puente A, Briones E, Arevalo M, et al. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int. 2010; 77:861–869.
8. Grant PJ. Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab. 2003; 29(4 Pt 2):6S44–6S52.
9. Jo YS, Choi SM, Lee J, Park YS, Lee CH, Yim JJ, et al. Effect of preadmission metformin use on clinical outcome of acute respiratory distress syndrome among critically ill patients with diabetes. Tuberc Respir Dis. 2017; 80:296–303.
10. Lemyze M, Baudry JF, Collet F, Guinard N. Life threatening lactic acidosis. BMJ. 2010; 340:c857.
11. Cho YJ, Moon JY, Shin ES, Kim JH, Jung H, Park SY, et al. Clinical practice guideline of acute respiratory distress syndrome. Tuberc Respir Dis. 2016; 79:214–233.